ETFOptimize | High-performance ETF-based Investment Strategies

Quantitative strategies, Wall Street-caliber research, and insightful market analysis since 1998.


ETFOptimize | HOME
Close Window

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Eargo, Inc. (Nasdaq – EAR), Miromatrix Medical, Inc. (Nasdaq – MIRO), Physicians Realty Trust (NYSE – DOC), Spirit Realty Capital (NYSE – SRC)

BALA CYNWYD, Pa., Oct. 30, 2023 (GLOBE NEWSWIRE) -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.

Eargo, Inc. (Nasdaq – EAR)

Under the terms of the Merger Agreement, Eargo will be acquired by Patient Square Capital for $2.55 per share in cash for each share of Eargo held. The investigation concerns whether the Eargo Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether Patient Square Capital is paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/eargo-inc-nasdaq-ear/.

Miromatrix Medical, Inc. (Nasdaq – MIRO)

Under the terms of the agreement, Miromatrix will be acquired by United Therapeutics Corporation (“United Therapeutics”) (Nasdaq – UTHR). United Therapeutics will commence a tender offer to acquire all outstanding shares of Miromatrix for a purchase price of $3.25 per share in cash at closing and an additional $1.75 per share in cash upon the achievement of a clinical development milestone related to Miromatrix’s development-stage, fully-implantable manufactured kidney product known as mirokidney™ by December 31, 2025. The investigation concerns whether the Miromatrix Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether United Therapeutics is paying fair value to shareholders of the Company.

Additional information can be found at https://www.brodskysmith.com/cases/miromatrix-medical-inc-nasdaq-miro

Physicians Realty Trust (NYSE – DOC)

Under the terms of the Merger Agreement, Physicians Realty Trust will be acquired by Healthpeak Properties, Inc.(“Healthpeak”) (NYSE – PEAK). Each Physicians Realty Trust common share will be converted into 0.674 of a newly issued Healthpeak common share. Healthpeak and Physicians Realty Trust shareholders will own approximately 77% and 23% of the combined company, respectively. The investigation concerns whether the Physicians Realty Trust Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to the Company’s shareholders in the combined company.

Additional information can be found at https://www.brodskysmith.com/cases/physicians-realty-trust-nyse-doc/.

Spirit Realty Capital (NYSE – SRC)

Under the terms of the agreement, Spirit Realty will be acquired by Realty Income Corporation (“Realty Income”) (NYSE – O). Spirit Realty shareholders will receive 0.762 newly-issued Realty Income common shares for each Spirit common share they own. At closing, this will result in Realty Income and Spirit Realty shareholders owning approximately 87% and 13%, respectively, of the combined company. The investigation concerns whether the Spirit Realty Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to Spirit Realty shareholders in the combined company.

Additional information can be found at https://www.brodskysmith.com/cases/spirit-realty-capital-inc-nyse-src/

Brodsky & Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.


Primary Logo

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.


 

IntelligentValue Home
Close Window

DISCLAIMER

All content herein is issued solely for informational purposes and is not to be construed as an offer to sell or the solicitation of an offer to buy, nor should it be interpreted as a recommendation to buy, hold or sell (short or otherwise) any security.  All opinions, analyses, and information included herein are based on sources believed to be reliable, but no representation or warranty of any kind, expressed or implied, is made including but not limited to any representation or warranty concerning accuracy, completeness, correctness, timeliness or appropriateness. We undertake no obligation to update such opinions, analysis or information. You should independently verify all information contained on this website. Some information is based on analysis of past performance or hypothetical performance results, which have inherent limitations. We make no representation that any particular equity or strategy will or is likely to achieve profits or losses similar to those shown. Shareholders, employees, writers, contractors, and affiliates associated with ETFOptimize.com may have ownership positions in the securities that are mentioned. If you are not sure if ETFs, algorithmic investing, or a particular investment is right for you, you are urged to consult with a Registered Investment Advisor (RIA). Neither this website nor anyone associated with producing its content are Registered Investment Advisors, and no attempt is made herein to substitute for personalized, professional investment advice. Neither ETFOptimize.com, Global Alpha Investments, Inc., nor its employees, service providers, associates, or affiliates are responsible for any investment losses you may incur as a result of using the information provided herein. Remember that past investment returns may not be indicative of future returns.

Copyright © 1998-2017 ETFOptimize.com, a publication of Optimized Investments, Inc. All rights reserved.